Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Stroka
    wrote on sidst redigeret af
    #455

    Kursmålet var tidligere 2.700

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #456

      ungee...Artiklen er låst. Jeg har skrevet til ØU om at åbne den. Vores aftale er, at "Langers Skarpe" hver lørdag er åben for vore brugere.

      1 Reply Last reply
      0
      • U Offline
        U Offline
        ungeee
        wrote on sidst redigeret af
        #457

        Super Helge - vil gerne læse den...

        1 Reply Last reply
        0
        • exitnuE Offline
          exitnuE Offline
          exitnu
          wrote on sidst redigeret af
          #458

          Super 🙂

          1 Reply Last reply
          0
          • Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktør
            wrote on sidst redigeret af
            #459

            "Langers Skarpe" er åben nu. https://www.proinvestor.com/investornyt/672839/langers-skarpe-her-er-forklaringen-pa-ugens-blodbad-i-danske-aktier

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #460

              Mygind notes that higher/ faster investments mean some extra risk. I had not realised people would think that way? I would argue that Genmab decides how to proceed after each development phase with each additional data point they get. To get to that data point they need to do an investment, the size of which will not depend much on the speed they get there.

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #461

                To me it is clear that, IF there is an adverse event in one of the projects, they will stop the development and therefore not use the full budget for that project. Whether you get there slow or fast. They recently showed their discipline in cutting development in Enapotamab and, in a sense, also with Camidanlumab.

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #462

                  Genmab could have also chosen to guide initially with lower costs and increase guidance after each successfully finished development phase. As is said before, to me, budgetting the fast development already now, shows conviction that they think that their projects will be successful.

                  1 Reply Last reply
                  0
                  • D Offline
                    D Offline
                    Doublo
                    wrote on sidst redigeret af
                    #463

                    Enig EL men det giver usikkerhed, at investeringen i udviklingsportefølgen er 1 milliard højere for 2021
                    , end der er udmeldt før regnskabet.

                    1 Reply Last reply
                    0
                    • D Offline
                      D Offline
                      Doublo
                      wrote on sidst redigeret af
                      #464

                      De sidste tal fra Genmab
                      jeg har noteret før regnskabet er omkring 3,85-3,95 mia. kr.

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #465

                        that was 2020 guidance, wasn't it?

                        1 Reply Last reply
                        0
                        • D Offline
                          D Offline
                          Doublo
                          wrote on sidst redigeret af
                          #466

                          StockBull Genmab sælger ikke, og hvis de overhovedet overvejede det, så ville kursen ikke være på det nuværende niveau, hvorfor i alverden skulle de gøre det??

                          1 Reply Last reply
                          0
                          • troldmandenT Offline
                            troldmandenT Offline
                            troldmanden
                            wrote on sidst redigeret af
                            #467

                            Det flugter også præcis med hvad jeg skrev tidligere. Jo mere aggrasivt man investere, jo mere risiko løber man. Hvis man fulgte den mere "normale" udvikling så vil man udvikle mod 1 fase 3 først samtidigt med der laves endnu flere PK studier. Og når man så har fase 3 data og de er gode så skruere man meget mere op. Derved er risikoen lavere. Modsat tager det længere tid at få et ligende antal godkendelser såfremt data er positive

                            1 Reply Last reply
                            0
                            • troldmandenT Offline
                              troldmandenT Offline
                              troldmanden
                              wrote on sidst redigeret af
                              #468

                              Så det er et kalkuleret satsning Abbvie og genmab fortager. Fejler det bliver det mega max dyrt at fejle fordi de kommer til at køre så mange parellle fase 3 forsøg

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #469

                                But are you now not explicitly assuming that when you fail on efficacy in one disease indication, they would not try it in anohter indication?

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #470

                                  Genmab Investor Presentation - March 2021
                                  https://ir.genmab.com/static-files/de962be4-2ada-4f94-b566-080b5ed340eb

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #471

                                    Canada

                                    @CADTH_ACMTS

                                    CADTH has issued a final recommendation that ofatumumab
                                    (#Kesimpta) be reimbursed with clinical criteria and/or conditions for the treatment of adult patients with relapsing remitting #MultipleSclerosis.

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #472

                                      POLITICO @politico
                                      BREAKING: The Senate passed President Biden’s $1.9 trillion coronavirus relief package after a marathon session and last-minute arm twisting over one of the biggest provisions in the package https://www.politico.com/news/2021/03/06/senate-approves-bidens-19t-pandemic-relief-plan-473920 …

                                      1 Reply Last reply
                                      0
                                      • FrittenF Offline
                                        FrittenF Offline
                                        Fritten
                                        wrote on sidst redigeret af
                                        #473

                                        Tror i den pakke vil give os lidt ro eller?

                                        1 Reply Last reply
                                        0
                                        • StockBullS Offline
                                          StockBullS Offline
                                          StockBull
                                          wrote on sidst redigeret af
                                          #474

                                          @Doublo. Der er masser af firmaer som bliver opkøbt når kursen er presset i bund så det kan selvfølgelig også ske for Genmab. Hvordan skulle Genmab kunne forhindre et opøb hvis storaktionærne ønsker at sælge deres aktier til højestbydende ?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger